A STOMP-focused evaluation of prescribing practices in one assessment and treatment unit for people with intellectual disabilities

PAINTER, Jon, CHIO, Winola, BLACK, Liam and NEWMAN, David (2022). A STOMP-focused evaluation of prescribing practices in one assessment and treatment unit for people with intellectual disabilities. Tizard Learning Disability Review.

[img]
Preview
PDF
Painter-AStompFocusedEvaluation(VoR).pdf - Published Version
Creative Commons Attribution.

Download (119kB) | Preview
Official URL: https://www.emerald.com/insight/content/doi/10.110...
Open Access URL: https://www.emerald.com/insight/content/doi/10.110... (Published)
Link to published version:: https://doi.org/10.1108/TLDR-04-2022-0008
Related URLs:

    Abstract

    Purpose This study aims to understand whether psychotropic prescribing practices for people with intellectual disabilities are in keeping with best practice guidelines. Design/methodology/approach This service evaluation project was a retrospective analysis of routinely collected data from the care records of all 36 people with intellectual disability discharged from an intellectual disability assessment and treatment unit during the first five years of the Stop Over medicating People with Intellectual Disabilities and/or autistic people (STOMP) initiative. Data were gathered at four time points (pre-admission, discharge, 6- and 12-month follow-up) before being analysed to understand whether psychotropic prescribing differed among people with different clinical characteristics/traits/diagnoses. Changes over time were also explored to ascertain whether and how prescribing altered from admission to discharge, and over the subsequent year of community living. Findings Most people with intellectual disabilities left the assessment and treatment unit on fewer regular psychotropic medications and at lower doses than at admission. These optimised regimes were still apparent 12 months post-discharge, suggesting effective discharge planning and community care packages. Inpatients with severe intellectual disabilities generally received more anxiolytics and hypnotics, at higher doses. Autistic people tended to receive more psychotropics in total and at higher cumulative doses, a pattern that persisted post discharge. A third of the sample were admitted on regular anti-psychotic medications despite having no corresponding psychotic diagnosis, a proportion that remained relatively stable through discharge and into the community. Originality/value This study highlights subsets of the intellectual disability population at particular risk of receiving high doses of psychotropics and a feasible template for providers intending to undertake STOMP-focused evaluations.

    Item Type: Article
    Uncontrolled Keywords: 1303 Specialist Studies in Education; 1607 Social Work
    Identification Number: https://doi.org/10.1108/TLDR-04-2022-0008
    SWORD Depositor: Symplectic Elements
    Depositing User: Symplectic Elements
    Date Deposited: 09 Aug 2022 09:58
    Last Modified: 20 Dec 2022 13:56
    URI: https://shura.shu.ac.uk/id/eprint/30566

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics